HUP0000137A2 - Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítmény - Google Patents
Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítményInfo
- Publication number
- HUP0000137A2 HUP0000137A2 HU0000137A HUP0000137A HUP0000137A2 HU P0000137 A2 HUP0000137 A2 HU P0000137A2 HU 0000137 A HU0000137 A HU 0000137A HU P0000137 A HUP0000137 A HU P0000137A HU P0000137 A2 HUP0000137 A2 HU P0000137A2
- Authority
- HU
- Hungary
- Prior art keywords
- anangetics
- controller
- pharmaceutical composition
- composition containing
- release pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000000202 analgesic effect Effects 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A találmány tárgya orálisan adagolandó készítmény, amelyben legalábbegy analgetikum mm átmérőjű mikrotablettákban helyezkedik el, ésamelyben az analgetikum szabályozott módon szabadul fel. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19901683A DE19901683B4 (de) | 1999-01-18 | 1999-01-18 | Analgetikum mit kontrollierter Wirkstofffreisetzung |
Publications (3)
Publication Number | Publication Date |
---|---|
HU0000137D0 HU0000137D0 (en) | 2000-03-28 |
HUP0000137A2 true HUP0000137A2 (hu) | 2001-02-28 |
HUP0000137A3 HUP0000137A3 (en) | 2001-03-28 |
Family
ID=7894562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0000137A HUP0000137A3 (en) | 1999-01-18 | 2000-01-17 | Controller-release pharmaceutical composition containing anangetics |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1020183A3 (hu) |
JP (1) | JP2000212069A (hu) |
KR (1) | KR20000071245A (hu) |
CN (1) | CN1270028A (hu) |
AR (1) | AR021934A1 (hu) |
AU (1) | AU777330B2 (hu) |
CA (1) | CA2295469A1 (hu) |
CO (1) | CO4910117A1 (hu) |
DE (1) | DE19901683B4 (hu) |
HU (1) | HUP0000137A3 (hu) |
IL (1) | IL134075A0 (hu) |
NZ (1) | NZ502260A (hu) |
PE (1) | PE20001453A1 (hu) |
PL (1) | PL337868A1 (hu) |
RU (1) | RU2244541C2 (hu) |
SK (1) | SK652000A3 (hu) |
ZA (1) | ZA200000171B (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19901687B4 (de) * | 1999-01-18 | 2006-06-01 | Grünenthal GmbH | Opioide Analgetika mit kontrollierter Wirkstofffreisetzung |
SK285128B6 (sk) * | 1999-12-28 | 2006-07-07 | Zentiva, A. S. | Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy |
US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
CN100356907C (zh) * | 2001-06-08 | 2007-12-26 | 恩德制药公司 | 利用丙烯酸酯聚合物的控释剂型和其制备方法 |
PE20030527A1 (es) | 2001-10-24 | 2003-07-26 | Gruenenthal Chemie | Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
MY135852A (en) | 2003-04-21 | 2008-07-31 | Euro Celtique Sa | Pharmaceutical products |
EP1479381A1 (en) * | 2003-05-19 | 2004-11-24 | Euro-Celtique S.A. | Pharmaceutical dosage form comprising a solid solution |
CN100336501C (zh) * | 2003-08-06 | 2007-09-12 | 健乔信元医药生技股份有限公司 | 醋炎痛缓释性圆粒组成物及制备方法 |
US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
JP5269595B2 (ja) | 2005-09-09 | 2013-08-21 | アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー | 1日1回投与用トラゾドン組成物 |
DE102006006532B4 (de) | 2006-02-10 | 2007-11-08 | Biogenerics Pharma Gmbh | Pharmazeutische Zubereitung |
SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
DE102008056312A1 (de) | 2008-11-07 | 2010-05-12 | Biogenerics Pharma Gmbh | Verwendung von Mikrotabletten als Lebens-und Futtermittelzusatz |
KR101378973B1 (ko) * | 2012-04-13 | 2014-03-28 | 한미약품 주식회사 | 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR5138M (hu) * | 1966-01-26 | 1967-06-05 | ||
CA1341504C (en) * | 1988-03-25 | 2006-04-11 | Jun Akimitsu | Substituted superconductive bi-sr-ca-cu oxide and bi-sr-ca-ln-cu oxide compositions |
IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
IT1243341B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizione farmaceutica per uso orale a rilascio modificato di antiinfiammatori non steroidei |
HU218673B (hu) * | 1993-10-07 | 2000-10-28 | Euroceltique S.A. | Opioid analgetikumot tartalmazó elnyújtott hatóanyag-felszabadítású orális gyógyszerkészítmény és eljárás előállítására |
EP0654263B1 (en) * | 1993-11-23 | 2002-01-23 | Euro-Celtique S.A. | Method for preparing a sustained release composition |
JP3739410B2 (ja) * | 1997-07-02 | 2006-01-25 | ユーロ−セルティーク エス.エイ. | 安定化された徐放性トラマドール製剤 |
US6156342A (en) * | 1998-05-26 | 2000-12-05 | Andex Pharmaceuticals, Inc. | Controlled release oral dosage form |
-
1999
- 1999-01-18 DE DE19901683A patent/DE19901683B4/de not_active Expired - Fee Related
- 1999-12-20 AR ARP990106587A patent/AR021934A1/es unknown
- 1999-12-21 EP EP99125471A patent/EP1020183A3/de not_active Withdrawn
-
2000
- 2000-01-04 PE PE2000000003A patent/PE20001453A1/es not_active Application Discontinuation
- 2000-01-05 AU AU10107/00A patent/AU777330B2/en not_active Ceased
- 2000-01-11 NZ NZ502260A patent/NZ502260A/en unknown
- 2000-01-14 JP JP2000006880A patent/JP2000212069A/ja not_active Withdrawn
- 2000-01-14 CA CA002295469A patent/CA2295469A1/en not_active Abandoned
- 2000-01-14 KR KR1020000001691A patent/KR20000071245A/ko not_active Application Discontinuation
- 2000-01-17 CN CN00104185A patent/CN1270028A/zh active Pending
- 2000-01-17 PL PL00337868A patent/PL337868A1/xx not_active Application Discontinuation
- 2000-01-17 SK SK65-2000A patent/SK652000A3/sk unknown
- 2000-01-17 ZA ZA200000171A patent/ZA200000171B/xx unknown
- 2000-01-17 CO CO00002025A patent/CO4910117A1/es unknown
- 2000-01-17 RU RU2000101023/15A patent/RU2244541C2/ru not_active IP Right Cessation
- 2000-01-17 HU HU0000137A patent/HUP0000137A3/hu unknown
- 2000-01-17 IL IL13407500A patent/IL134075A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE19901683B4 (de) | 2005-07-21 |
ZA200000171B (en) | 2000-08-07 |
DE19901683A1 (de) | 2000-07-20 |
PL337868A1 (en) | 2000-07-31 |
RU2244541C2 (ru) | 2005-01-20 |
SK652000A3 (en) | 2000-08-14 |
IL134075A0 (en) | 2001-04-30 |
AR021934A1 (es) | 2002-09-04 |
JP2000212069A (ja) | 2000-08-02 |
PE20001453A1 (es) | 2000-12-23 |
EP1020183A3 (de) | 2000-09-20 |
HUP0000137A3 (en) | 2001-03-28 |
AU777330B2 (en) | 2004-10-14 |
CA2295469A1 (en) | 2000-07-18 |
KR20000071245A (ko) | 2000-11-25 |
CO4910117A1 (es) | 2000-04-24 |
NZ502260A (en) | 2002-02-01 |
CN1270028A (zh) | 2000-10-18 |
HU0000137D0 (en) | 2000-03-28 |
EP1020183A2 (de) | 2000-07-19 |
AU1010700A (en) | 2000-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0000137A2 (hu) | Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítmény | |
CO5251419A1 (es) | Composiciones nanoparticuladas de eplerenona | |
GB2431346B (en) | A combination composition comprising paracetamol and ibuprofen | |
CR6210A (es) | Composiciones de celecoxib | |
NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
HUP0203623A2 (hu) | Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
YU36700A (sh) | Oralni farmaceutski oblik za doziranje sa produženim oslobađanjem | |
ATE486840T1 (de) | Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür | |
BG66093B1 (bg) | Състави с контролирано освобождаване, съдържащи нимесулид | |
UY27296A1 (es) | Composición farmacéutica que contiene mosaprida y pancreatina | |
AR042051A1 (es) | Tratamiento combinado contra el cancer con un compuesto anti-cancerigeno activado por glutationa s- transferasa (gst) y otro tratamiento contra el cancer | |
TR200101719T2 (tr) | Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımı | |
AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
TR200201071T2 (tr) | Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi | |
CO5570661A2 (es) | Combinaciones que comprenden inhibidores de cox-2 y aspirina | |
AR022621A1 (es) | Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina | |
AR036321A1 (es) | Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia. | |
ATE410152T1 (de) | Therapeutisches system mit amoxicillin und clavulansäure | |
ATE421357T1 (de) | Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizität | |
BR0108261A (pt) | Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono | |
HUP0402326A2 (hu) | Gyógyszerkészítmény addikció megelőzésére fájdalom kezelésében | |
AR024981A1 (es) | Composicion para la prevencion y el tratamiento de las disfunciones y enfermedades del rinon | |
SE0000303D0 (sv) | Novel compounds | |
DK1152763T3 (da) | Anvendelse af desozypeganin til behandling af stofafhængighed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |